Asylia Therapeutics
Biotechnology Research • 
Houston, Texas, United States • 1-10 Employees
Company overview
| Headquarters | Houston, Texas, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2019 |
| Employees | 1-10 |
| Socials |
Key Contact at Asylia Therapeutics
Richard Jones
Chief Executive Officer
Asylia Therapeutics Email Formats
Asylia Therapeutics uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@asyliatx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@asyliatx.com | 100% |
About Asylia Therapeutics
Asylia Therapeutics is a private development stage biotechnology company committed to transforming scientific advances into safe and effective medicines for cancer and auto-immune diseases.
Asylia Therapeutics revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Asylia Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Asylia Therapeutics has never raised funding before.
Asylia Therapeutics Tech Stack
Discover the technologies and tools that power Asylia Therapeutics's digital infrastructure, from frameworks to analytics platforms.
WordPress themes
JavaScript libraries
JavaScript libraries
Page builders
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Cookie compliance
Germany
United Kingdom
Frequently asked questions
4.8
40,000 users
